Improving continuity of clinical care and educating general practitioners – development and evaluation of information sheets about chemotherapy for general practitioners

Phase 1

Recruiting

• Conditions: Cancer (general); Cancer -

• Registration Number: ACTRN12606000215527
• Lead Sponsor: Peter Macallum Cancer Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-05-31
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

To be eligible GPs must:1.Be the nominated GP of a patient with a defined cancer type, who is scheduled to commence a defined chemotherapy regimen 2.Agree to be randomised to either the intervention group who will receive faxed or e-mailed information or to the usual contact group3.Agree to participate in two brief telephone surveys (‘pre’ and ‘post’)4.Provide verbal informed consent to participate in this study

Exclusion Criteria

To be eligible GPs must not:1.have already been enrolled in this study (if the same GP is treating two patients who are receiving chemotherapy in the Day Ward at Peter MacCallum Cancer Centre only the 1st patient will be included in this study)2. have a patient is is receiving concurrent radiotherapy.All age ranges and both genders will be included within the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified